Drug Type Peptides |
Synonyms SDC-487-131 |
Target |
Action agonists |
Mechanism SDC4 agonists(syndecan 4 agonists), αvβ1 agonists(Integrin alpha-V/beta-1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pulmonary Fibrosis | Preclinical | China | 16 Jul 2025 |





